Synthekine Investors

16 investors on Angel Roster list Synthekine in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Synthekine can appear together.

Investors listed
16
With verified email
63%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 16 Synthekine investors

The most complete profiles first. Showing 16 of 16.

  • David GoeddelVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more

    Verified email available

  • Eric YoungVerified

    Venture Capital, Founder, Investor · United Kingdom

    SeedSeries BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Filanet, Hallo and 85 more

    Verified email available

  • Guy RussoVerified

    Venture Capital, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Verified email available

  • Jared NewmanVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Verified email available

  • Joydeep BhattacharyyaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceCybersecurity

    Portfolio: BoostUp.ai, Node, OncoResponse, Hallo and 84 more

    Verified email available

  • Laura ChauVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Verified email available

  • Peter SvennilsonVerified

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more

    Verified email available

  • Tim ShannonVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 83 more

    Verified email available

  • Hootan RashidifardVerified

    Venture Capital · United States

    AdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Verified email available

  • Nandu Anilal

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Contact details available

  • Rayfe Gaspar

    Venture Capital, Private Equity Firm, Investor · United States

    Series BSeries AAdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Contact details available

  • Tim Kutzkey

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more

    Contact details available

  • Byron Ling

    Venture Capital · United States

    AdvertisingHealth CareE-commerceMessaging

    Portfolio: Node, OncoResponse, Hallo, SeeTree and 81 more

    Contact details available

  • JJ Kang

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more

    Contact details available

  • James Evangelista

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more

    Contact details available

  • Julie GrantVerified

    Venture Capital, Private Equity Firm, Angel/Individual · United States

    Series BSeries AE-commerceCloud ComputingSoftwareBiotechnology

    Portfolio: Protagonist Therapeutics, Synthekine

    Verified email available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Synthekine investors are on Angel Roster?

Angel Roster lists 16 Synthekine investors. 10 of them (63%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (16), Private Equity Firms (9) and Founder-Investors (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Synthekine investors invest in?

Among those that list a stage, the most common are Series B (9), Series A (9) and Seed (4).

Where are Synthekine investors based?

Most are based in the United States (15) and the United Kingdom (1).

Which companies have Synthekine investors backed?

The most-backed portfolio companies among them are Agile Stacks (10), Ladder (10), Vineti (10), Synova Life Sciences (10) and Taptap Send (10).

How do I contact Synthekine investors?

Create a free Angel Roster account to search and filter all 16, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.